J.M. Liddell, PhD

Billingham

United Kingdom

J.M.Liddell, PhD, is head of process science at Avecia Biologics Ltd.

Articles

Production Strategies for Antibody Fragment Therapeutics

Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.